Form 4: Centene Corp Director Acquires Shares in Year-End Transaction

Centene Corp director Frederick H. Eppinger acquired 414 shares of common stock on December 31, 2024, increasing his total holdings to 352,198.658 shares.

Summary

• Director Frederick H. Eppinger acquired 414 shares of Centene Corp common stock on December 31, 2024.
• The acquisition was made at a price of $0 per share, likely due to the nature of the transaction.
• Following the transaction, Eppinger's total direct holdings in Centene Corp amount to 352,198.658 shares.
• This total includes 4,861 shares of restricted stock units that are subject to vesting requirements.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing regarding a director's stock transaction, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This is a routine filing related to a director's stock transactions and is common in publicly traded companies. It does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders in publicly traded companies, such as Centene Corp, and are required by the SEC.
• The transaction is similar to those of other directors at comparable companies, such as UnitedHealth Group (UNH) or CVS Health (CVS), who also regularly report their stock transactions.
• The acquisition of shares by a director is a common occurrence and does not necessarily indicate a significant change in the company's performance or outlook.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine director stock acquisition.

Key Dates

Keywords

Centene Corp, Director, Share Acquisition, Form 4, Stock Ownership, Frederick H. Eppinger, Restricted Stock Units